Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 249

The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.

Reliable assessment of the effects of treatment on mortality and major morbidity, II: observational studies

MacMahon, Stephen, Collins, Rory·2001·The Lancet

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(00)04017-4

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 14 references

Research works printed but not linked: 57

  1. Collins, 2001, Reliable assessment of the effects of treatmenton mortality and major morbidity, I: clinical trials, Lancet, 357, 373, 10.1016/S0140-6736(00)03651-5 · DOI · Paper page
  2. Mellin, 1962, The saga of thalidomide, N Engl J Med, 267, 1184, 10.1056/NEJM196212062672305 · DOI · Paper page
  3. Herbst, 1971, Adenocarcinoma of the vagina: association of maternal stilbestrol therapy with tumor appearance in young women, N Engl J Med, 284, 878, 10.1056/NEJM197104222841604 · DOI · Paper page
  4. Khan, 1998, The prevalence of cardiac valvular insufficiency assessed by transthoracic echocardiography in obese patients treated with appetite-suppressant drugs, N Engl J Med, 339, 713, 10.1056/NEJM199809103391101 · DOI · Paper page
  5. Grady, 1992, Hormone therapy to prevent disease and prolong life in postmenopausal women, Ann Intern Med, 117, 1016, 10.7326/0003-4819-117-12-1016 · DOI · Paper page
  6. Beral, 1999, Use of HRT and the subsequent risk of cancer, J Epidemiol Biostats, 4, 191
  7. Florey, 1943, General and local administration of penicillin, Lancet, 1, 387, 10.1016/S0140-6736(00)41962-8 · doi:10.1016/s0140-6736(00)41962-8
  8. Harington, 1959, Results of treatment in malignant hypertension: a seven-year experience in 94 cases, BMJ, 2, 969, 10.1136/bmj.2.5158.969 · DOI · Paper page
  9. Mahalanabis, 1973, Oral fluid therapy of cholera among Bangladesh refugees, Johns Hopkins Med J, 132, 197
  10. Hennekens, 1993, Observational evidence, Ann N Y Acad Sci, 703, 18, 10.1111/j.1749-6632.1993.tb26330.x · DOI
  11. Lever, 1998, Do inhibitors of angiotensin-Iconverting enzyme protect against risk of cancer?, Lancet, 352, 179, 10.1016/S0140-6736(98)03228-0 · DOI · Paper page
  12. Barrett-Connor, 1998, Hormone replacement therapy, heart disease, and other considerations, Annu Rev Public Health, 19, 55, 10.1146/annurev.publhealth.19.1.55 · DOI · Paper page
  13. Barrett-Connor, 1998, Hormone replacement therapy, BMJ, 17, 457, 10.1136/bmj.317.7156.457 · DOI · Paper page
  14. Jick, 2000, Statins and the risk of dementia, Lancet, 356, 1627, 10.1016/S0140-6736(00)03155-X · DOI · Paper page
  15. Soumerai, 1997, Adverse outcomes of underuse of β-blockers in elderly survivors of acute myocardial infarction, JAMA, 277, 115, 10.1001/jama.1997.03540260029031 · doi:10.1001/jama.1997.03540260029031 · Paper page
  16. Doughty, 1997, Effects of betablocker therapy on mortality in patients with heart failure: a systematic overview of randomized controlled trials, Eur Heart J, 18, 560, 10.1093/oxfordjournals.eurheartj.a015297 · DOI · Paper page
  17. 1999, The Cardiac Insufficiency Bisoprolol Study II (CIBIS II): a randomised trial, Lancet, 353, 9, 10.1016/S0140-6736(98)11181-9 · DOI · Paper page
  18. Clarke, 1999, Underestimation of risk associations due to regression dilution in long-term follow-up of prospective studies, Am J Epidemiol, 150, 341, 10.1093/oxfordjournals.aje.a010013 · DOI · Paper page
  19. Thurmer, 1994, Is blood pressure treatment as effective in a population setting as in controlled trials? Results from a prospective study, J Hypertens, 12, 481
  20. Collins, 1994, Blood pressure, antihypertensive drug treatment and the risks of stroke and of coronary heart disease, Br Med Bull, 50, 272, 10.1093/oxfordjournals.bmb.a072892 · DOI · Paper page
  21. Paganini-Hill, 1989, Aspirin use and chronic diseases: a cohort study of the elderly, BMJ, 299, 1247, 10.1136/bmj.299.6710.1247 · DOI · Paper page
  22. 1994, Collaborative overview of randomised trials of antiplatelet therapy. I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients, BMJ, 308, 81, 10.1136/bmj.308.6921.81 · DOI · Paper page
  23. Barnett, 1998, Benefit of carotid endar terectomy in patients with symptomatic moderate or severe stenosis, N Engl J Med, 339, 1415, 10.1056/NEJM199811123392002 · DOI · Paper page
  24. Taylor, 1999, Low-dose and high-dose acetylsalicylic acid for patients undergoing carotid endar terectomy: a randomised controlled trial, Lancet, 353, 2179, 10.1016/S0140-6736(99)05388-X · DOI · Paper page
  25. Swan, 1992, Reporting and selection bias in case control studies of congenital malformations, Epidemiology, 3, 356, 10.1097/00001648-199207000-00011 · DOI
  26. Stewart, 1958, A survey of childhood malignancies, BMJ, 1, 1495, 10.1136/bmj.1.5086.1495 · doi:10.1136/bmj.1.5086.1495
  27. MacMahon, 1964, Prenatal x-ray and childhood cancer: a review, Acta Unio Int Contra Cancrum, 20, 1172
  28. Khoury, 1994, On the use of affected controls to address recall bias in case-controlled studies of birth defects, Teratology, 49, 273, 10.1002/tera.1420490407 · DOI
  29. 1996, Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies, Lancet, 347, 1713, 10.1016/S0140-6736(96)90806-5 · DOI · Paper page
  30. Bar-Oz, 1999, Reporting bias in retrospective ascertainment of drug-induced embryopathy, Lancet, 354, 1700, 10.1016/S0140-6736(99)04411-6 · DOI
  31. Psaty, 1995, The risk of myocardial infarction associated with antihypertensive drug therapies, JAMA, 274, 620, 10.1001/jama.1995.03530080036038 · DOI · Paper page
  32. 2000, Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials, Lancet, 355, 1955
  33. McClellan, 1994, Does more intensive treatment of acute myocardial infarction in the elderly reduce mortality? Analysis using instrumental variables, JAMA, 272, 859, 10.1001/jama.1994.03520110039026 · DOI · Paper page
  34. Gargiullo, 1999, Principles of epidemiological research on drug effects, Lancet, 353, 501, 10.1016/S0140-6736(05)75177-1 · doi:10.1016/s0140-6736(05)75177-1
  35. MacDonald, 1999, Principles of epidemiological research on drug effects, Lancet, 353, 501, 10.1016/S0140-6736(05)75178-3 · doi:10.1016/s0140-6736(05)75178-3
  36. Barbone, 1998, Association of road-traffic accidents with benzodiazepine use, Lancet, 352, 1331, 10.1016/S0140-6736(98)04087-2 · DOI · Paper page
  37. Rubin, 1997, Estimating causal effects from large data sets using propensity scores, Ann Intern Med, 127, 757, 10.7326/0003-4819-127-8_Part_2-199710151-00064 · DOI · Paper page
  38. 1997, Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancer, Lancet, 350, 1047, 10.1016/S0140-6736(97)08233-0 · DOI · Paper page
  39. Matthews, 1996, Prior to use of estrogen replacement therapy, are users healthier than nonusers?, Am J Epidemiol, 143, 971, 10.1093/oxfordjournals.aje.a008678 · DOI · Paper page
  40. Barrett-Connor, 1991, Postmenopausal estrogen and prevention bias, Ann Intern Med, 115, 455, 10.7326/0003-4819-115-6-455 · DOI · Paper page
  41. Giovannucci, 1996, Physical activity, obesity, and risk of colorectal adenoma in women (United States), Cancer Causes Control, 7, 253, 10.1007/BF00051301 · DOI · Paper page
  42. Larkin, 2000, Ups and downs for HRT and heart disease, Lancet, 355, 1338, 10.1016/S0140-6736(05)72573-3 · doi:10.1016/s0140-6736(05)72573-3
  43. Moss, 1981, Digitalis-associated cardiac mortality after myocardial infarction, Circulation, 64, 1150, 10.1161/01.CIR.64.6.1150 · DOI · Paper page
  44. Lindsay, 1999, For the UK Heart Investigation. Digoxin and mortality in chronic heart failure, Lancet, 354, 1003, 10.1016/S0140-6736(99)03815-5 · DOI
  45. Spargias, 1999, Safety concerns about digoxin after acute myocardial infarction, Lancet, 354, 391, 10.1016/S0140-6736(99)01429-4 · DOI
  46. McKee, 1999, Interpreting the evidence: choosing between randomised and nonrandomized studies, BMJ, 319, 312, 10.1136/bmj.319.7205.312 · DOI · Paper page
  47. 1974, Report from the Boston Collaborative Drug Surveillance Program. Reserpine and breast cancer, Lancet, 2, 669
  48. Heinonen, 1974, Reserpine use in relation to breast cancer, Lancet, 2, 675, 10.1016/S0140-6736(74)93259-0 · DOI · Paper page
  49. Horwitz, 1985, Exclusion bias and the false relationship of reserpine and breast cancer, Arch Intern Med, 145, 1873, 10.1001/archinte.1985.00360100139023 · DOI
  50. Pahor, 1996, Calcium-channel blockade and incidence of cancer in aged populations, Lancet, 348, 493, 10.1016/S0140-6736(96)04277-8 · DOI · Paper page
  51. Law, 1994, By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease?, BMJ, 308, 367, 10.1136/bmj.308.6925.367 · DOI · Paper page
  52. LaRosa, 1999, Effect of statins on risk of coronary disease: a meta-analysis of randomized controlled trials, JAMA, 282, 2340, 10.1001/jama.282.24.2340 · DOI · Paper page
  53. Peto, 1981, Can dietary beta-carotene materially reduce human cancer rates?, Nature, 290, 201, 10.1038/290201a0 · DOI · Paper page
  54. Hennekens, 1996, Lack of effect of long term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease, N Engl J Med, 334, 1145, 10.1056/NEJM199605023341801 · DOI · Paper page
  55. Danesh, 1998, Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies, JAMA, 279, 1477, 10.1001/jama.279.18.1477 · DOI · Paper page
  56. Danesh, 1998, Plasma homocysteine and coronary heart disease: systematic review of published epidemiological studies, J Cardiol Risk, 5, 229, 10.1097/00043798-199808000-00004 · DOI · Paper page
  57. 1997, Effects of calcium antagonists on the risks of coronary heart disease, cancer and bleeding, J Hypertens, 15, 105

Cited by

See all 249

Metadata

Authors
MacMahon, S., & Collins, R.
Venue
The Lancet
Publisher
Elsevier BV
Published
2001-02
Volume
357
Issue
9254
Pages
455-462
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
OpenAlex
W2100630414
Cited by
249
References
14
FWCI
21.70
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Reliable assessment of the effects of treatment on mortality and major morbidity, II: observational studies. https://app.cochat.ai/papers/10.1016/s0140-6736(00)04017-4
The paper
MacMahon, S., & Collins, R. (2001). Reliable assessment of the effects of treatment on mortality and major morbidity, II: observational studies. The Lancet. https://doi.org/10.1016/s0140-6736(00)04017-4

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.